• Filing Date: 2020-07-09
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed and Consolidated Financial Statements for Entities in Bankruptcy - Condensed and Consolidated Balance Sheet (Details) - USD ($)
$ / shares in Units, $ in Thousands
May 31, 2020
Feb. 29, 2020
Nov. 30, 2019
May 31, 2019
Feb. 28, 2019
Nov. 30, 2018
Jul. 17, 2017
Jul. 16, 2017
ASSETS                
Cash and cash equivalents $ 21,284   $ 24,283 [1]          
Life settlements, at estimated fair value 0   1,297 [1]          
Total assets 175,122   165,712 [1]          
Liabilities                
Accounts payable and accrued expenses 951   1,651 [1]          
Total liabilities 115,856   123,599 [1]          
Share Capital (1 share of $1 authorized and issued) 1,593   1,584 [1]          
Additional paid-in-capital 334,620   334,576 [1]          
Accumulated deficit/retained earnings (274,413)   (291,513) [1]          
Total stockholders’ equity 59,266 $ 54,582 42,113 [1] $ (35,923) $ (10,136) $ 27,242    
Total liabilities and stockholders’ equity $ 175,122   $ 165,712 [1]          
Common stock, par value (in dollars per share) $ 0.01   $ 0.01 [1]          
Common stock, shares authorized (in shares) 415,000,000   415,000,000 [1]       415,000,000 80,000,000
Common stock, shares issued (in shares) 159,263,140   158,365,275 [1] 158,659,803        
Subsidiaries | Lamington                
ASSETS                
Cash and cash equivalents $ 0     $ 8,703        
Prepaid expenses and other assets 0     606        
Life settlements, at estimated fair value 0     475,551        
Receivable for maturity of life settlements 0     46,190        
Total assets 0     531,050        
Liabilities                
Accounts payable and accrued expenses 0     8,501        
Other liabilities (subject to compromise) 0     7,588        
Revolving Credit Facility debt, at estimated fair value 0     394,570        
Promissory notes payable (subject to compromise) 0     146,393        
Total liabilities 0     557,052        
Share Capital (1 share of $1 authorized and issued) 0     0        
Additional paid-in-capital 0     60,602        
Accumulated deficit/retained earnings 0     (86,604)        
Total stockholders’ equity 0     (26,002)        
Total liabilities and stockholders’ equity $ 0     $ 531,050        
Common stock, par value (in dollars per share) $ 1   $ 1          
Common stock, shares authorized (in shares) 1   1          
Common stock, shares issued (in shares) 1   1          
[1] Derived from audited consolidated financial statements.